Attività Cambiamento Data
AstraZeneca USD 115.83B 1.82B 2026-06
Genmab DKK 12.52B 139M 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Qiagen NV USD 5.89B 107.14M 2026-06
UCB EUR 18.16B 971M 2025-12